SCHEMBL2907901

SCHEMBL2907901

CCOC(=O)c1cnc2cc(OCC)c(N3CCN(C(C)C)CC3)cc2c1Nc1cc(C)ccc1F

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 7/20 0.63
SCN5A Q14524 4/20 0.63
CSF1R P07333 8/20 0.56
MAPT P10636 4/20 0.49
GAA P10253 3/20 0.49
MEN1 O00255 2/20 0.49
LMNA P02545 2/20 0.49
MC4R P32245 2/20 0.49
HTT P42858 2/20 0.49
KMT2A Q03164 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
TDP1 Q9NUW8 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
PTK2B Q14289 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
MAPK1 P28482 1/20 0.43
CLK1 P49759 1/20 0.43
GSK3A P49840 1/20 0.43
GSK3B P49841 1/20 0.43
THRB P10828 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2912075 0.93 KCNH2 (0.61) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL1276767 0.92 KCNH2 (0.74) KCNH2SCN5ACSF1R
SCHEMBL2907152 0.91 KCNH2 (0.75) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2912181 0.91 KCNH2 (0.65) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2912835 0.90 KCNH2 (0.63) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2914184 0.89 CSF1R (0.70) KCNH2SCN5ACSF1RMAPTLMNA
SCHEMBL2913052 0.89 KCNH2 (0.71) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2909522 0.88 KCNH2 (0.69) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2910088 0.87 KCNH2 (0.61) KCNH2SCN5ACSF1RMAPTGAA
SCHEMBL2910312 0.87 KCNH2 (0.60) KCNH2SCN5ACSF1RMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2010496-B1 4-ANILINOQUINOLINE-3-CARBOXAMIDES AS CSF-1R KINASE INHIBITORS ASTRAZENECA AB (SE) 2010-08-25 EP disclosed